Gabelli Funds’s Haemonetics HAE Stock Holding History

Gabelli Funds’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$717K	Sell	12,722 -1,000	-7%	-$65.1K	﹤0.01%	974
2025 Q4	$1.1M	Hold	13,722	–	–	0.01%	883
2025 Q3	$669K	Buy	13,722 +3,040	+28%	+$188K	﹤0.01%	1003
2025 Q2	$797K	Buy	+10,682	New	+$707K	0.01%	944
2022 Q3	–	Sell	-6,500	Closed	-$424K	–	1363
2022 Q2	$424K	Hold	6,500	–	–	﹤0.01%	1050
2022 Q1	$411K	Hold	6,500	–	–	﹤0.01%	1092
2021 Q4	$345K	Hold	6,500	–	–	﹤0.01%	1156
2021 Q3	$459K	Hold	6,500	–	–	﹤0.01%	1093
2021 Q2	$433K	Buy	+6,500	New	+$460K	﹤0.01%	1095

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gabelli Funds's HAE Position: Q1 2026 in Review

Gabelli Funds reduced its Haemonetics (HAE) stake by 7.3% in Q1 2026, selling an estimated $65.1K and leaving 12,722 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #974.

Gabelli Funds first reported a position in HAE in Q2 2021 and has held it in 9 quarters since. The position peaked at $1.1M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Gabelli Funds held 12,722 shares of Haemonetics worth $717K as of Q1 2026.
Gabelli Funds sold 1,000 Haemonetics shares in Q1 2026, an estimated $65.1K.
Haemonetics made up ﹤0.01% of Gabelli Funds's portfolio in Q1 2026, its #974 holding.
Gabelli Funds first reported a position in Haemonetics in Q2 2021 and has held it in 9 quarters since.
Gabelli Funds's Haemonetics position peaked at $1.1M in Q4 2025.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.